CERo Therapeutics Holdings, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|
Revenue | $1,162 | $0 | $0 |
Gross Profit | 581 | -293 | |
EBITDA | -2,720 | -4,402 | -2,138 |
EBIT | -2,139 | -2,431 | |
Net Income | -2,112 | -4,227 | -2,448 |
Net Change In Cash | 1,162 | 0 | 0 |
Free Cash Flow | 4,145 | -1,318 | -3,537 |
Cash | 3,327 | 3,380 | 3,647 |
Basic Shares | 49,675 | 16,198 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -2,441 | -68 | -332 |
EBIT | -2,444 | -1,141 | -1,067 |
Net Income | -2 | -667 | -315 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -1 | -1,786 | -1,309 |
Cash | 96 | 42,141 | 1,098 |
Basic Shares | 6,528 | 6,769 | 22,981 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$8.51 |
2024-06-30 | -$15.11 |
2024-03-31 | -$15.63 |
2023-12-31 | -$4.52 |
